Dallas, TX -- (SBWIRE) -- 05/25/2012 -- About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Conventional radiotherapy equipment http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html like X-rays, gamma rays, and charged particles comprises of high-energy radiation beams capable of shrinking tumors and killing cancer causing cells. Approximately 70% of all the cancer patients globally undergo radiation therapy. Also, it has been identified that almost 20% of malignant tumors are radiation-resistant; in such cases neutron based radiation therapy are proven to be more effective as compared to conventional radiating sources due to its intense ionizing property. According to the research done, the application of fast neutron therapy as compared with traditional methods of therapy for malignant tumors increases the effectiveness of treatment by 20-40%, improves quality and increases the life expectancy of patients.
The radiation can be delivered via:
- External-Beam Radiation Therapy (EBRT)
- Internal Radiation Therapy (IRT) – Brachytherapy
- Systemic Radiation Therapy (Systemic radiation therapy uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells).
The market is also segmented by various technologies like Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), cyber knife, gamma knife, proton / neutron therapy, Dynamic Multi-Leaf Collimator (DMLC) and other major technologies. The radiotherapy market is also estimated by Monitoring Devices http://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html like intraoperative x-ray (fluoroscopic) guidance, digital mammography & ultrasound systems, computed tomography systems, magnetic resonance and Positron Emission Tomography – CT (PET-CT). The major applications covered in this market are Oncology, Cardiology and Neurology. The geographic analysis of regions like North America, Europe, APAC and Rest of the World (ROW) is covered.
The Radiotherapy Equipment Market is expected to grow beyond USD 5 billion in another 5 to 7 years with a double digit CAGR. EBRT will continue to hold the major share in this market fuelled by ever increasing patient pool eligible for radiation therapy.
About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website htpp://www.marketsandmarkets.com
Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
MarketsandMarkets Blog [ http://www.marketsandmarketsblog.com ]
http://www.marketsandmarkets.com
http://twitter.com/marketsmarkets